NCT02506673

Brief Summary

Little is known about perioperative stress responses and possible anxiety mitigating factors like audiovisual aids or IV sedation. Most studies use surrogate markers and retrospective questionnaires, and are not based on real-time gathered data. Skin conductance measurements allow the sympathetic discharge to be evaluated down to fractions of a second and enable us to continuously monitor stress responses as skin conductance responses/per second during the perioperative management. In our study, the investigators propose to examine the effect of personal audiovisual equipment (audio/video goggles) on perioperative stress, pain, and overall experience in patients undergoing ambulatory meniscectomy under spinal anesthesia. Patients will be randomly assigned to either receive traditional sedation or light sedation in addition to audiovisual equipment. The investigators hope to determine outcome estimates of the use of this equipment on stress levels using skin conductance measurements, request for further sedation, postoperative pain levels and analgesic consumption, time to discharge readiness, and overall patient satisfaction, and collect thus far unavailable data on the stress response to perioperative stresses (such as IV insertion and spinal placement) in order to allow for power analyses for future studies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2015

Completed
21 days until next milestone

First Posted

Study publicly available on registry

July 23, 2015

Completed
6 months until next milestone

Study Start

First participant enrolled

January 14, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
2.6 years until next milestone

Results Posted

Study results publicly available

February 10, 2020

Completed
Last Updated

December 27, 2024

Status Verified

April 1, 2024

Enrollment Period

1.3 years

First QC Date

July 2, 2015

Results QC Date

September 7, 2018

Last Update Submit

December 23, 2024

Conditions

Keywords

Audiovisual AidsPerioperative PeriodAnxiety

Outcome Measures

Primary Outcomes (1)

  • Skin Conductance Response

    Primary outcome will be number of skin conductance responses per second (SCR/sec) and amplitude of skin conductance responses averaged over time in 5 minute intervals and at key time points such before, during and after insertion of an IV, discussion with surgeon, anesthesiologist, immediately before leaving the holding area, immediately after entering the OR, during application of monitors, before and after administration of sedatives, before, during and after spinal insertion, incision, immediately prior to leaving the OR, after arrival at PACU and monitors are placed, before discharge from the PACU.

    Measured in 5 minute intervals, from holding area until PACU discharge.

Secondary Outcomes (12)

  • Beats Per Minute (BPM)

    Measured from preop to postop

  • Systolic and Diastolic Blood Pressure

    Measured from preop to postop

  • Respiratory Rate

    Measured from preop to postop

  • Number of Patients Who Requested Additional Sedation

    In the operating room

  • Pain Numerical Rating Scale (NRS) Levels

    Holding area, Postop (PACU, 30 minutes after arrival to PACU and POD1)

  • +7 more secondary outcomes

Study Arms (2)

Sedation only with skin conductance monitor

ACTIVE COMPARATOR

Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.

Drug: MidazolamDevice: Skin Conductance Monitor

Sedation & audiovisual aids with skin conductance monitor

EXPERIMENTAL

Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.

Device: Zeiss, Cinema ProMED (audiovisual equipment)Drug: MidazolamDevice: Skin Conductance Monitor

Interventions

Sedation & audiovisual aids with skin conductance monitor
Sedation & audiovisual aids with skin conductance monitorSedation only with skin conductance monitor
Sedation & audiovisual aids with skin conductance monitorSedation only with skin conductance monitor

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for primary, ambulatory, arthroscopic meniscectomy under spinal anesthesia

You may not qualify if:

  • Patients with psychiatric disease and those on antidepressants
  • Contraindications to spinal anesthesia or allergy to study medication
  • Age \< 18 years
  • Patients with audiovisual impairments
  • Patients with inability to communicate in English or understand the study requirements
  • Chronic pain patients +/- opioid use
  • Patients with (neuro)dermatoses encompassing the hand
  • Patients with pacemakers
  • Patients with diabetes or known neuropathic disease
  • Patients with a history of epilepsy or seizure disorder
  • Patients with a history of claustrophobia
  • Patients with a history of epilepsy
  • Patients with prior history of epilepsy or seizure disorder
  • Patients undergoing a revision or open procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital for Special Surgery (HSS)

New York, New York, 10021, United States

Location

MeSH Terms

Conditions

Stress, PsychologicalAnxiety Disorders

Interventions

Midazolam

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Intervention Hierarchy (Ancestors)

BenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Results Point of Contact

Title
Danya DeMeo, Research Assistant
Organization
Hospital for Special Surgey

Study Officials

  • Stavros G. Memtsoudis, MD, PhD

    Hospital for Special Surgery, New York

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2015

First Posted

July 23, 2015

Study Start

January 14, 2016

Primary Completion

May 1, 2017

Study Completion

July 1, 2017

Last Updated

December 27, 2024

Results First Posted

February 10, 2020

Record last verified: 2024-04

Locations